5 Tips To Guide Your EHR Through Meaningful Use Stage 2
Posted: April 29th, 2014 | Author: Jodi | Filed under: Basics, In the News, Incentives, Newsletter, Public Policy, Standards | Tags: CMS, DoseSpot, e-Prescribing, e-Prescribing Software, EHR, EHR software, healthIT, meaningful use, MU, ONC, Stage 2 | No Comments »
FollowLooking for tips to navigate MU stage 2 requirements?  View one tip on drug-drug and drug-allergy interaction checks below and visit http://www.dosespot.com/meaningful-use-tips to download all 5 certification tips!
Meaningful Use Stage 2:Â Tip #2Â –
§ 170.314(a)(2) Drug-drug, drug-allergy interaction checks
Objective:Â In addition to providing drug-drug and drug-allergy interaction checks, this criteria requires EHRs to adjust the level of interactions based on user roles (ie: administrator).
Tip:Â Provide an easy-to-use user interface so a user can quickly adjust the interactions. DoseSpot allows the user to turn on and off the drug-drug and drug-allergy interactions as well adjust the severity level display between minor, moderate and major interactions.
Click here for more blog posts at ePrescribing.org on Meaningful Use.
Leave a Reply